Trademark: 98107763
Word
RHEEGEN
Status Date
Friday, September 27, 2024
Filing Date
Friday, July 28, 2023
Published for Opposition
Tuesday, May 7, 2024
5 Anti-inflammatory gels; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; Medicaments to help assist with the regeneration of ligament and tendon fibers; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Topical first aid gel; Topical gel for medical and therapeutic treatment of Osteoarthritis, muscle sprain, muscle strain, muscle ache
The mark consists of capitalized word RHEEGEN in black with stylized letter G in the form of a DNA helix.
Color is not claimed as a feature of the mark.
Aug 28, 2023
New Application Office Supplied Data Entered
Aug 1, 2023
New Application Entered
Mar 29, 2024
Previous Allowance Count Withdrawn
Mar 29, 2024
Assigned To Examiner
Mar 29, 2024
Approved For Pub - Principal Register
Mar 29, 2024
Examiners Amendment E-Mailed
Mar 29, 2024
Examiners Amendment -Written
Mar 29, 2024
Notification Of Examiners Amendment E-Mailed
Mar 29, 2024
Examiner's Amendment Entered
Mar 29, 2024
Approved For Pub - Principal Register
May 7, 2024
Published For Opposition
Apr 17, 2024
Notification Of Notice Of Publication E-Mailed
Jul 2, 2024
Noa E-Mailed - Sou Required From Applicant
May 7, 2024
Official Gazette Publication Confirmation E-Mailed
Jul 17, 2024
Teas Statement Of Use Received
Sep 19, 2024
Statement Of Use Processing Complete
Sep 19, 2024
Case Assigned To Intent To Use Paralegal
Sep 27, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 27, 2024
Allowed Principal Register - Sou Accepted
Jul 17, 2024
Use Amendment Filed
Trademark Alertz updated from USPTO on 2030-01-24
